| Clinical data | |
|---|---|
| Other names | 6α-Methyl-17α-bromopregn-4-en-3,20-dione |
| Identifiers | |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C22H31BrO2 |
| Molar mass | 407.392 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
6α-Methyl-17α-bromoprogesterone is asteroidalprogestin related tohaloprogesterone (6α-fluoro-17α-bromoprogesterone) that was described in 1963 and was never marketed.[1]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byadding missing information. |